# News # News Categories [Alzheimer's disease](/news-and-resources/news/category/alzheimer%27s-disease/) [Friedreich's Ataxia](/news-and-resources/news/category/friedreich%27s-ataxia/) [Huntingtons Disease](/news-and-resources/news/category/huntingtons-disease/) [CHDI](/news-and-resources/news/category/chdi/) [HD-IH](/news-and-resources/news/category/hd-ih/) [Global Alzheimers Program](/news-and-resources/news/category/global-alzheimers-program/) [PET Imaging](/news-and-resources/news/category/pet-imaging/) [MRI](/news-and-resources/news/category/mri/) [Multiple Sclerosis](/news-and-resources/news/category/multiple-sclerosis/) [White Matter Imaging](/news-and-resources/news/category/white-matter-imaging/) [Neuroinflammation](/news-and-resources/news/category/neuroinflammation/) [amyloid PET](/news-and-resources/news/category/amyloid-pet/) [PET](/news-and-resources/news/category/pet/) [diversity in clinical trials](/news-and-resources/news/category/diversity-in-clinical-trials/) [Organisational News](/news-and-resources/news/category/organisational-news/) Library [November 2026](/news-and-resources/news/archive/2026/11/) [October 2026](/news-and-resources/news/archive/2026/10/) [September 2026](/news-and-resources/news/archive/2026/09/) [July 2026](/news-and-resources/news/archive/2026/07/) [June 2026](/news-and-resources/news/archive/2026/06/) [May 2026](/news-and-resources/news/archive/2026/05/) [April 2026](/news-and-resources/news/archive/2026/04/) [March 2026](/news-and-resources/news/archive/2026/03/) [February 2026](/news-and-resources/news/archive/2026/02/) [January 2026](/news-and-resources/news/archive/2026/01/) [2025](/news-and-resources/news/archive/2025/) [2024](/news-and-resources/news/archive/2024/) [2023](/news-and-resources/news/archive/2023/) [2022](/news-and-resources/news/archive/2022/) [2021](/news-and-resources/news/archive/2021/) [2020](/news-and-resources/news/archive/2020/) [2019](/news-and-resources/news/archive/2019/) [ Categories ](javascript:void(0);) [Alzheimer's disease](/news-and-resources/news/category/alzheimer%27s-disease/) [Friedreich's Ataxia](/news-and-resources/news/category/friedreich%27s-ataxia/) [Huntingtons Disease](/news-and-resources/news/category/huntingtons-disease/) [CHDI](/news-and-resources/news/category/chdi/) [HD-IH](/news-and-resources/news/category/hd-ih/) [Global Alzheimers Program](/news-and-resources/news/category/global-alzheimers-program/) [PET Imaging](/news-and-resources/news/category/pet-imaging/) [MRI](/news-and-resources/news/category/mri/) [Multiple Sclerosis](/news-and-resources/news/category/multiple-sclerosis/) [White Matter Imaging](/news-and-resources/news/category/white-matter-imaging/) [Neuroinflammation](/news-and-resources/news/category/neuroinflammation/) [amyloid PET](/news-and-resources/news/category/amyloid-pet/) [PET](/news-and-resources/news/category/pet/) [diversity in clinical trials](/news-and-resources/news/category/diversity-in-clinical-trials/) [Organisational News](/news-and-resources/news/category/organisational-news/) [ Library ](javascript:void(0);) [November 2026](/news-and-resources/news/archive/2026/11/) [October 2026](/news-and-resources/news/archive/2026/10/) [September 2026](/news-and-resources/news/archive/2026/09/) [July 2026](/news-and-resources/news/archive/2026/07/) [June 2026](/news-and-resources/news/archive/2026/06/) [May 2026](/news-and-resources/news/archive/2026/05/) [April 2026](/news-and-resources/news/archive/2026/04/) [March 2026](/news-and-resources/news/archive/2026/03/) [February 2026](/news-and-resources/news/archive/2026/02/) [January 2026](/news-and-resources/news/archive/2026/01/) [2025](/news-and-resources/news/archive/2025/) [2024](/news-and-resources/news/archive/2024/) [2023](/news-and-resources/news/archive/2023/) [2022](/news-and-resources/news/archive/2022/) [2021](/news-and-resources/news/archive/2021/) [2020](/news-and-resources/news/archive/2020/) [2019](/news-and-resources/news/archive/2019/) [ ![IXICO announces £2.7 million Phase 3 contract win in Huntington’s disease](/assets/blog-images/HD-contract-win__ScaleMaxWidthWzgwMF0_FillMaxWzgwMCw0NTBd_ExtRewriteWyJwbmciLCJ3ZWJwIl0.webp) ](/news-and-resources/news/2-7-million-phase-3-contract-win-in-huntingtons-disease/) 2 Nov 26 news [ IXICO announces £2.7 million Phase 3 contract win in Huntington’s disease ](/news-and-resources/news/2-7-million-phase-3-contract-win-in-huntingtons-disease/) [ Read more ](/news-and-resources/news/2-7-million-phase-3-contract-win-in-huntingtons-disease/) [ ![IXICO presents research on novel methods to reduce unwanted variability in Huntington’s disease biomarker data ](/assets/blog-images/HD-novel-methods__ScaleMaxWidthWzgwMF0_FillMaxWzgwMCw0NTBd_ExtRewriteWyJwbmciLCJ3ZWJwIl0.webp) ](/news-and-resources/news/ixico-presents-research-on-novel-methods-to-reduce-unwanted-variability-in-huntingtons-disease-biomarker-data/) 29 Oct 26 news [ Novel methods to reduce unwanted variability in Huntington’s disease biomarker data ](/news-and-resources/news/ixico-presents-research-on-novel-methods-to-reduce-unwanted-variability-in-huntingtons-disease-biomarker-data/) [ Read more ](/news-and-resources/news/ixico-presents-research-on-novel-methods-to-reduce-unwanted-variability-in-huntingtons-disease-biomarker-data/) [ ![IXICO announces two contracts in Alzheimer's disease worth £1.5 million](/assets/blog-images/AD-contract-advancements__ScaleMaxWidthWzgwMF0_FillMaxWzgwMCw0NTBd_ExtRewriteWyJwbmciLCJ3ZWJwIl0.webp) ](/news-and-resources/news/ixico-announces-two-contracts-in-alzheimers-disease-worth-1-5-million/) 22 Oct 26 news [ IXICO announces two contracts in Alzheimer's disease worth £1.5 million ](/news-and-resources/news/ixico-announces-two-contracts-in-alzheimers-disease-worth-1-5-million/) [ Read more ](/news-and-resources/news/ixico-announces-two-contracts-in-alzheimers-disease-worth-1-5-million/) [ ![IXICO announces 28% expected revenue growth for FY26](/assets/blog-images/Trading-update-FY26__ScaleMaxWidthWzgwMF0_FillMaxWzgwMCw0NTBd_ExtRewriteWyJwbmciLCJ3ZWJwIl0.webp) ](/news-and-resources/news/ixico-trading-update-for-year-ending-30-september-2026/) 20 Oct 26 news [ IXICO announces 28% expected revenue growth for FY26 ](/news-and-resources/news/ixico-trading-update-for-year-ending-30-september-2026/) [ Read more ](/news-and-resources/news/ixico-trading-update-for-year-ending-30-september-2026/) [ ![IXICO to present advancements in neuroimaging for Parkinson’s disease at European radiology conference ](/assets/blog-images/advancements-in-neuroimaging-for-Parkinsons-disease__ScaleMaxWidthWzgwMF0_FillMaxWzgwMCw0NTBd_ExtRewriteWyJwbmciLCJ3ZWJwIl0.webp) ](/news-and-resources/news/ixico-to-present-advancements-in-neuroimaging-for-parkinsons-disease/) 1 Oct 26 news [ IXICO to present advancements in neuroimaging for Parkinson’s disease ](/news-and-resources/news/ixico-to-present-advancements-in-neuroimaging-for-parkinsons-disease/) [ Read more ](/news-and-resources/news/ixico-to-present-advancements-in-neuroimaging-for-parkinsons-disease/) [ ![IXICO EXPANDS RESEARCH COLLABORATIONS IN ALZHEIMER’S AND PARKINSON’S DISEASE](/assets/blog-images/IXICO-EXPANDS-RESEARCH-COLLABORATIONS-IN-ALZHEIMERS-AND-PARKINSONS-DISEASE-1__ScaleMaxWidthWzgwMF0_FillMaxWzgwMCw0NTBd_ExtRewriteWyJqcGciLCJ3ZWJwIl0.webp) ](/news-and-resources/news/ixico-expands-research-collaborations-in-alzheimers-and-parkinsons-disease/) 8 Jun 26 news [ IXICO EXPANDS RESEARCH COLLABORATIONS IN ALZHEIMER’S AND PARKINSON’S DISEASE ](/news-and-resources/news/ixico-expands-research-collaborations-in-alzheimers-and-parkinsons-disease/) [ Read more ](/news-and-resources/news/ixico-expands-research-collaborations-in-alzheimers-and-parkinsons-disease/) [ ![IXICO reports strong H1 revenue growth as Alzheimer’s trial demand accelerates](/assets/blog-images/CEO-Interview-Interim-Results__ScaleMaxWidthWzgwMF0_FillMaxWzgwMCw0NTBd_ExtRewriteWyJwbmciLCJ3ZWJwIl0.webp) ](/news-and-resources/news/ixico-reports-strong-h1-revenue-growth-as-alzheimers-trial-demand-accelerates/) 19 May 26 news [ IXICO reports strong H1 revenue growth as Alzheimer’s trial demand accelerates ](/news-and-resources/news/ixico-reports-strong-h1-revenue-growth-as-alzheimers-trial-demand-accelerates/) [ Read more ](/news-and-resources/news/ixico-reports-strong-h1-revenue-growth-as-alzheimers-trial-demand-accelerates/) [ ![Interim results for six months ending 31 March 2026. Continued strong revenue and order book growth.](/assets/blog-images/Interim-Results__ScaleMaxWidthWzgwMF0_FillMaxWzgwMCw0NTBd_ExtRewriteWyJqcGciLCJ3ZWJwIl0.webp) ](/news-and-resources/news/ixico-plc/) 19 May 26 news [ Interim results for six months ending 31 March 2026. Continued strong revenue and order book growth. ](/news-and-resources/news/ixico-plc/) [ Read more ](/news-and-resources/news/ixico-plc/) [ ![IXICO RELEASES LATEST VERSION OF AI-DRIVEN NEUROIMAGING TECHNOLOGY PLATFORM](/assets/blog-images/IXI-_10-Resease_2__ScaleMaxWidthWzgwMF0_FillMaxWzgwMCw0NTBd_ExtRewriteWyJwbmciLCJ3ZWJwIl0.webp) ](/news-and-resources/news/ixico-releases-latest-version-of-ai-driven-neuroimaging-technology-platform/) 12 May 26 news [ IXICO RELEASES LATEST VERSION OF AI-DRIVEN NEUROIMAGING TECHNOLOGY PLATFORM ](/news-and-resources/news/ixico-releases-latest-version-of-ai-driven-neuroimaging-technology-platform/) [ Read more ](/news-and-resources/news/ixico-releases-latest-version-of-ai-driven-neuroimaging-technology-platform/) [ ![IXICO and Medidata collaborate to create an advanced neuroimaging clinical trials platform ](/assets/blog-images/MEDIDATA-Press-Release_3__ScaleMaxWidthWzgwMF0_FillMaxWzgwMCw0NTBd_ExtRewriteWyJqcGciLCJ3ZWJwIl0.webp) ](/news-and-resources/news/ixico-and-medidata-collaborate-to-create-an-advanced-neuroimaging-clinical-trials-platform/) 26 Mar 26 news [ IXICO and Medidata collaborate to create an advanced neuroimaging clinical trials platform ](/news-and-resources/news/ixico-and-medidata-collaborate-to-create-an-advanced-neuroimaging-clinical-trials-platform/) [ Read more ](/news-and-resources/news/ixico-and-medidata-collaborate-to-create-an-advanced-neuroimaging-clinical-trials-platform/) [ ![IXICO further validates the automation capabilities of its IXI™ neuroimaging technology platform](/assets/blog-images/Default-Header__ScaleMaxWidthWzgwMF0_FillMaxWzgwMCw0NTBd_ExtRewriteWyJwbmciLCJ3ZWJwIl0.webp) ](/news-and-resources/news/ixico-further-validates-the-automation-capabilities-of-its-ixi-neuroimaging-technology-platform/) 26 Feb 26 news [ IXICO further validates the automation capabilities of its IXI™ neuroimaging technology platform ](/news-and-resources/news/ixico-further-validates-the-automation-capabilities-of-its-ixi-neuroimaging-technology-platform/) [ Read more ](/news-and-resources/news/ixico-further-validates-the-automation-capabilities-of-its-ixi-neuroimaging-technology-platform/) [ ![c.£1.5 million contract extension on global Phase 2 clinical trial ](/assets/blog-images/Default-Header__ScaleMaxWidthWzgwMF0_FillMaxWzgwMCw0NTBd_ExtRewriteWyJwbmciLCJ3ZWJwIl0.webp) ](/news-and-resources/news/c-1-5-million-contract-extension-on-global-phase-2-clinical-trial/) 12 Feb 26 news [ c.£1.5 million contract extension on global Phase 2 clinical trial ](/news-and-resources/news/c-1-5-million-contract-extension-on-global-phase-2-clinical-trial/) [ Read more ](/news-and-resources/news/c-1-5-million-contract-extension-on-global-phase-2-clinical-trial/) [1](javascript:void(0);) [2](/news-and-resources/news/index.md?start=12) [3](/news-and-resources/news/index.md?start=24) [4](/news-and-resources/news/index.md?start=36) [Prev](javascript:void(0);) [Next](/news-and-resources/news/index.md?start=12) 1 - 12 of 45 results ## Sign-up to the latest from IXICO